# Triple-Hormone-Receptor Agonist Retatrutide for Obesity. Reply.

> PubMed lists PMID 37888927 in The New England journal of medicine as Letter, Comment, with publication-date metadata of 2023-10-26 (day precision). PeptideScanner associated the retained record with the identity slug retatrutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-37888927-retatrutide:v1`
- Evidence domain: Literature metadata
- Date in source: 2025-07-03
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-37888927-retatrutide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-37888927-retatrutide-v1.json
- Content SHA-256: `89fb56244b273aeb95f50acdd8260819a47ccb2e2cc0a99168f50b1b2bd08a59`

## Claims and source pins

### Headline

Triple-Hormone-Receptor Agonist Retatrutide for Obesity. Reply. ([`pubmed-observation-pmid-37888927-2025-07-03-99a9ba785360`](#source-pubmed-observation-pmid-37888927-2025-07-03-99a9ba785360))

### Summary

PubMed lists PMID 37888927 in The New England journal of medicine as Letter, Comment, with publication-date metadata of 2023-10-26 (day precision). PeptideScanner associated the retained record with the identity slug retatrutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-37888927-2025-07-03-99a9ba785360`](#source-pubmed-observation-pmid-37888927-2025-07-03-99a9ba785360))

### Paragraph 1

PubMed lists PMID 37888927 in The New England journal of medicine as Letter, Comment, with publication-date metadata of 2023-10-26 (day precision). PeptideScanner associated the retained record with the identity slug retatrutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-37888927-2025-07-03-99a9ba785360`](#source-pubmed-observation-pmid-37888927-2025-07-03-99a9ba785360))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-37888927-2025-07-03-99a9ba785360`](#source-pubmed-observation-pmid-37888927-2025-07-03-99a9ba785360))

## Sources

<a id="source-pubmed-observation-pmid-37888927-2025-07-03-99a9ba785360"></a>
- **Triple-Hormone-Receptor Agonist Retatrutide for Obesity. Reply. · retained source version 1:2025-07-03:current:99a9ba7853606c489dc7e3178591fcfcd9c0129419b674f26c070b90c7a3f411** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/37888927/) (`pubmed-observation-pmid-37888927-2025-07-03-99a9ba785360`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Triple-Hormone-Receptor Agonist Retatrutide for Obesity. Reply." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-37888927-retatrutide-v1.json SHA-256: 89fb56244b273aeb95f50acdd8260819a47ccb2e2cc0a99168f50b1b2bd08a59.